Compare DRTS & KOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRTS | KOP |
|---|---|---|
| Founded | 2015 | 1988 |
| Country | Israel | United States |
| Employees | 121 | N/A |
| Industry | Medical/Dental Instruments | Forest Products |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 978.2M | 784.7M |
| IPO Year | N/A | 2005 |
| Metric | DRTS | KOP |
|---|---|---|
| Price | $9.73 | $44.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $8.67 | ★ $52.50 |
| AVG Volume (30 Days) | ★ 933.1K | 139.1K |
| Earning Date | 05-18-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 0.90% |
| EPS Growth | N/A | ★ 11.38 |
| EPS | N/A | ★ 0.35 |
| Revenue | N/A | ★ $1,879,300,000.00 |
| Revenue This Year | N/A | $2.91 |
| Revenue Next Year | $699.98 | $1.86 |
| P/E Ratio | ★ N/A | $124.67 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.87 | $25.00 |
| 52 Week High | $11.62 | $46.40 |
| Indicator | DRTS | KOP |
|---|---|---|
| Relative Strength Index (RSI) | 52.32 | 58.73 |
| Support Level | $6.59 | $35.73 |
| Resistance Level | $11.48 | $46.40 |
| Average True Range (ATR) | 0.83 | 1.45 |
| MACD | -0.09 | 0.18 |
| Stochastic Oscillator | 39.92 | 67.40 |
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
Koppers Holdings Inc through its subsidiaries, manufactures and sells wood products, wood treatment chemicals, and carbon compounds used in markets such as railroad, aluminum and steel, agriculture, utilities, and residential lumber. The company is organized into three business segments: railroad and utility products and services, performance chemicals, and carbon materials and chemicals. Its product portfolio includes treated and untreated wood products like crossties used in railroads, wood preservation chemicals, and carbon compounds such as creosote used in the treatment of wood crossties, among others. The majority of its revenue comes from the company's railroad and utility products and services segment, and more than half of the company's revenue is earned in the United States.